2 min read

EverHint – SMA 20/50 Crossover – Top 4 Buy and Top 5 Sell Signals for Aug 27, 2026

9 signals (from 19 total). Healthcare leads (6). price range $15-$570. 1 with insider selling.

Excerpt: 9 signals (from 19 total). Healthcare leads (6). price range $15-$570. 1 with insider selling.

What This Signal Is

Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.

Entry Criteria:

  • Buy: SMA20 crosses above SMA50
  • Sell: SMA20 crosses below SMA50
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh crossover: Detected on today's close

Holding period: 2-6 weeks | Risk level: Medium

Market Context

Equity markets are displaying broad-based strength on August 27, 2026, with the Nasdaq leading gains at +1.57% and the S&P 500 adding a solid +0.71%. This divergence between tech-heavy and broader indices suggests growth-oriented risk appetite is driving the session, a favorable backdrop for momentum-based strategies like the SMA20/SMA50 crossover system. When faster moving averages are crossing above slower ones in an environment of rising prices and positive breadth, the probability of sustained follow-through improves meaningfully.

The VIX at 14.51, down nearly 5% on the day, reflects a notably calm volatility environment. Low implied volatility compresses intraday price swings, which generally reduces false signal noise for trend-following crossover strategies. However, it also means breakout moves may carry less explosive momentum — signals in this environment tend to produce steadier, more gradual trends rather than sharp directional moves, rewarding patience over aggressive position sizing.

Healthcare emerging as the top sector among today's 19 signals is a noteworthy rotation cue. Healthcare often attracts capital during periods of moderate risk appetite — neither full-on defensive nor aggressively cyclical — which aligns with the current mixed index performance (Dow lagging at +0.20% while Nasdaq surges). This suggests the market may be selectively rotating toward sectors with earnings stability and growth characteristics, making SMA crossover signals in Healthcare particularly relevant as they may reflect genuine institutional accumulation rather than speculative momentum.

🟢 Buy Signals (4 of 4 total)

Ranked by RSI (lower RSI = more oversold for buy signals)

# Ticker Company Sector Price Insider MCap
1 CNC Centene Corp. Healthcare $65.34 $32.3B
2 CRDO Credo Technology Group... Technology $240.24 $44.8B
3 CVCO Cavco Industries, Inc. Consumer Cyclical $570.27 $4.4B
4 MTRN Materion Corporation Basic Materials $246.15 $5.1B

🔴 Sell Signals (5 of 15 total)

Ranked by RSI (lower RSI = more oversold for buy signals)

# Ticker Company Sector Price Insider MCap
1 ACGL Arch Capital Group Ltd. Financial Services $98.76 $34.5B
2 AES The AES Corporation Utilities $14.71 $10.5B
3 AFL Aflac Incorporated Financial Services $116.59 Sell -$74,413 $59.3B
4 COGT Cogent Biosciences, Inc. Healthcare $37.09 $6.3B
5 DAL Delta Air Lines, Inc. Industrials $81.14 $53.4B

Field Notes

Sector concentration: Healthcare (6), Financial Services (3), Industrials (3)

Insider selling (7d): AFL (Aflac Incorporated, -$74,413)

Data coverage: 5.3% insider (7d), 0.0% congressional (30d), 0.0% earnings, 26.3% news (7d)

Peer Analysis

MTRN (Materion Corporation): Leads 5 peers: TMC ($5.09), BCC ($78.77), OLN ($17.28), SKE ($35.12), CSTM ($27.41)

Recent Headlines

ACGL (Arch Capital Group Ltd.)

  • Why Is Arch Capital (ACGL) Down 3.7% Since Last Earnings Report?
  • ACGL's Insurance Segment Faces Competitive and Margin Pressures

AES (The AES Corporation)

  • The AES Corporation $AES Shares Sold by Algert Global LLC

AFL (Aflac Incorporated)

  • 5 Dividend Aristocrats That Belong in Every Income Portfolio

Vlad's Take

Today's signals: Strong sector concentration in Healthcare (6 signals) suggests sector-specific rotation.


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📢 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.